YEATS2/TAK1 axis mediates TGF-beta1 driven adaptive resistance to sorafenib in hepatocellular carcinoma. Bai L, Wang Y, Li G, Song Y, et al. Biochem Biophys Res Commun 2026;817:153693.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bai L, Wang Y, Li G, Song Y, et al. YEATS2/TAK1 axis mediates TGF-beta1 driven adaptive resistance to sorafenib in hepatocellular carcinoma. Biochem Biophys Res Commun 2026;817:153693.
PMID: 41962409